Yang, L., Jianghu, Z., Jingbo, W., Runye, W., Xiaodong, H., Kai, W., . . . Junlin, Y. (2022, December). MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma. Radiology and Oncology.
Chicago Style (17th ed.) CitationYang, Liu, et al. "MRI-identified Multidimensional Nodal Features Predict Survival and Concurrent Chemotherapy Benefit for Stage II Nasopharyngeal Carcinoma." Radiology and Oncology Dec. 2022.
MLA (9th ed.) CitationYang, Liu, et al. "MRI-identified Multidimensional Nodal Features Predict Survival and Concurrent Chemotherapy Benefit for Stage II Nasopharyngeal Carcinoma." Radiology and Oncology, Dec. 2022.
Warning: These citations may not always be 100% accurate.
